A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 13,546 shares of BMRN stock, worth $906,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,546
Previous 13,424 0.91%
Holding current value
$906,091
Previous $1.11 Million 13.85%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$69.02 - $93.84 $8,420 - $11,448
122 Added 0.91%
13,546 $952,000
Q2 2024

Aug 14, 2024

SELL
$74.43 - $92.22 $5,582 - $6,916
-75 Reduced 0.56%
13,424 $1.11 Million
Q1 2024

May 09, 2024

BUY
$83.81 - $99.0 $754 - $891
9 Added 0.07%
13,499 $1.18 Million
Q4 2023

Mar 05, 2024

BUY
$76.22 - $98.51 $17,073 - $22,066
224 Added 1.69%
13,490 $1.3 Million
Q4 2023

Feb 06, 2024

BUY
$76.22 - $98.51 $1.01 Million - $1.31 Million
13,266 New
13,266 $1.28 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.